Sahm Adrangi Explains Why Proteostasis Therapeutics Stock Is Over Valued

Despite being 33 years old, Sahm Adrangi has made a name for himself in the financial industry. He is a private investment manager who operates his own business, Kerrisdale Capital Management, LLC. He is located in New York, New York and he has two focuses for his hedge fund. The first focus is on investing in long-term value investments. The second one is taking advantage of event-driven special situations. It is this latter focus which led him to short the stock of Proteostasis Therapeutics, Inc. and then release a negative report about this company.

Proteostasis Therapeutics is a firm which pretty much bases its entire value on one drug candidate, PTI-428. This drug is being evaluated for the treatment of cystic fibrosis. Their stock soared by 100% when PTI-428 was given both the Orphan Drug and Breakthrough Therapy designations by the Food and Drug Administration. However, Sahm Adrangi and his team presented their analysis that is drug is very likely ineffective. He issued a negative report indicating that Kerrisdale Capital saw a pattern of low-quality data in regard to this drug and some vital information was omitted from this company’s public disclosures.

Due to what he saw, Sahm Adrangi took a short position on this firm. This means that if their shares fall the fund he manages will make money. In his report he noted that he was going to have a conference call later that day where he and his team would go into more detail in what they discovered. This was held on March 20, 2018. at 10:30 a.m. ET. Anyone could call in and participate in this event.

Sahm Adrangi has been managing his investment firm since 2009. His company now manages $300 million which is mostly in value investments. He entered the financial industry in 2004 after graduating from Yale University. He worked as an analyst for a few different firms, such as Longacre Fund Management LLC, before deciding to open his own company. He was able to do so with his own money plus that of his family, friends, and other supporters.

http://www.businessinsider.com/meet-hedge-funder-sahm-adrangi-2013-10

Paul Mampilly Shares His View On Investment

Paul Mampilly, Profits Unlimited founder, is an investment analyst, and a good one, if I may add. He shares his investment opinions on a monthly basis through his eight-page newsletter which has over 60,000 subscribers.

Mampilly is a University at Albany, SUNY alumni. He started his career in 1991 at Bankers Trust, where he was an assistant portfolio manager. He has close to 25 years’ experience in the finance industry and has been a portfolio manager for Deutsche Bank and ING.

Mampilly has a record of success, and this is probably why his newsletter is doing so well. In it, he recommends investments and explains, in detail, why he is of the opinion that that is a good idea. His writing technique is simple in such a way that a new investor is able to understand the concept. This goes a long way in building trust because no one would be willing to invest if they feel that the advice given didn’t have a strong basis. He has great passion for helping others succeed and this is evident in every issue published. Once his subscribers receive their issue, they can visit his website where they can track stocks. On a weekly basis, Mampilly picks two of the recommended portfolios and gives updates. Mampilly portfolio has a success rate of approximately 85%, with one recently increasing by over 150%.

Instead of the traditional approach where brokers do all the work for their clients, Mampilly prefers empowering his clients. He teaches them the secret to becoming a smart investor. His clients set up and use their brokerage accounts on their own. He teaches them how to trade stocks, track information and update their portfolios. He has taken safety measures on his website such that any information that is client related is safe.

Nothing is as reassuring as frequent updates to a client, and Mampilly knows this. When trades must be made, he sends out trade alerts to his clients and includes instructions on how to trade. He doesn’t forget to remind them of the importance of trading. He also updates his subscribers with information on the newest stocks.

In 2009, Mampilly participated in an investment competition hosted by the Templeton Foundation and emerged the winner after he invested 50 million dollars and yielded 88 million dollars, a gain of more than 75%. The fact that he was able to yield such an amount during one of the worst recessions that the country had ever faced gained him a lot of positive publicity.

See: http://weeklyopinion.com/2017/08/benefiting-from-paul-mampillys-extraordinary-market-acumen/